172 related articles for article (PubMed ID: 1444804)
1. Manganese induced brain lesions in Macaca fascicularis as revealed by positron emission tomography and magnetic resonance imaging.
Eriksson H; Tedroff J; Thuomas KA; Aquilonius SM; Hartvig P; Fasth KJ; Bjurling P; Långström B; Hedström KG; Heilbronn E
Arch Toxicol; 1992; 66(6):403-7. PubMed ID: 1444804
[TBL] [Abstract][Full Text] [Related]
2. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
Antonini A; Schwarz J; Oertel WH; Beer HF; Madeja UD; Leenders KL
Neurology; 1994 Jul; 44(7):1325-9. PubMed ID: 8035939
[TBL] [Abstract][Full Text] [Related]
3. Effect of reserpine-induced depletion of synaptic dopamine on [11C]raclopride binding to D2-dopamine receptors in the monkey brain.
Ginovart N; Farde L; Halldin C; Swahn CG
Synapse; 1997 Apr; 25(4):321-5. PubMed ID: 9097390
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.
Antonini A; Leenders KL
Ann N Y Acad Sci; 1993 Sep; 695():81-5. PubMed ID: 8239318
[TBL] [Abstract][Full Text] [Related]
5. Amphetamine effects on dopamine release and synthesis rate studied in the Rhesus monkey brain by positron emission tomography.
Hartvig P; Torstenson R; Tedroff J; Watanabe Y; Fasth KJ; Bjurling P; Långström B
J Neural Transm (Vienna); 1997; 104(4-5):329-39. PubMed ID: 9295169
[TBL] [Abstract][Full Text] [Related]
6. Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease.
Antonini A; Vontobel P; Psylla M; Günther I; Maguire PR; Missimer J; Leenders KL
Arch Neurol; 1995 Dec; 52(12):1183-90. PubMed ID: 7492293
[TBL] [Abstract][Full Text] [Related]
7. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements of [11C]SCH23390 and [11C]raclopride binding in primate brains.
Ekesbo A; Torstenson R; Hartvig P; Carlsson A; Sonesson C; Waters N; Tedroff J; Långström B
Neuropharmacology; 1999 Mar; 38(3):331-8. PubMed ID: 10219971
[TBL] [Abstract][Full Text] [Related]
8. Difference in response of D2 receptor binding between 11C-N-methylspiperone and 11C-raclopride against anesthetics in rhesus monkey brain.
Kobayashi K; Inoue O; Watanabe Y; Onoe H; Långström B
J Neural Transm Gen Sect; 1995; 100(2):147-51. PubMed ID: 8962684
[TBL] [Abstract][Full Text] [Related]
9. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study.
Shinotoh H; Snow BJ; Chu NS; Huang CC; Lu CS; Lee C; Takahashi H; Calne DB
Neurology; 1997 Apr; 48(4):1053-6. PubMed ID: 9109899
[TBL] [Abstract][Full Text] [Related]
10. Neurological Wilson's disease studied with magnetic resonance imaging and with positron emission tomography using dopaminergic markers.
Westermark K; Tedroff J; Thuomas KA; Hartvig P; Långström B; Andersson Y; Hörnfeldt K; Aquilonius SM
Mov Disord; 1995 Sep; 10(5):596-603. PubMed ID: 8552111
[TBL] [Abstract][Full Text] [Related]
11. Progressive changes of pre- and post-synaptic dopaminergic biomarkers in conscious MPTP-treated cynomolgus monkeys measured by positron emission tomography.
Nagai Y; Obayashi S; Ando K; Inaji M; Maeda J; Okauchi T; Ito H; Suhara T
Synapse; 2007 Oct; 61(10):809-19. PubMed ID: 17598150
[TBL] [Abstract][Full Text] [Related]
12. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective binding of 11C-raclopride in living human brain--a search for extrastriatal central D2-dopamine receptors by PET.
Farde L; Pauli S; Hall H; Eriksson L; Halldin C; Högberg T; Nilsson L; Sjögren I; Stone-Elander S
Psychopharmacology (Berl); 1988; 94(4):471-8. PubMed ID: 3131792
[TBL] [Abstract][Full Text] [Related]
14. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients.
Farde L; Suhara T; Nyberg S; Karlsson P; Nakashima Y; Hietala J; Halldin C
Psychopharmacology (Berl); 1997 Oct; 133(4):396-404. PubMed ID: 9372541
[TBL] [Abstract][Full Text] [Related]
15. Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.
Sawle GV; Playford ED; Brooks DJ; Quinn N; Frackowiak RS
Brain; 1993 Aug; 116 ( Pt 4)():853-67. PubMed ID: 8353712
[TBL] [Abstract][Full Text] [Related]
16. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
17. Effect of age on D2 dopamine receptors in normal human brain measured by positron emission tomography and 11C-raclopride.
Antonini A; Leenders KL; Reist H; Thomann R; Beer HF; Locher J
Arch Neurol; 1993 May; 50(5):474-80. PubMed ID: 8489403
[TBL] [Abstract][Full Text] [Related]
18. Substituted benzamides as ligands for visualization of dopamine receptor binding in the human brain by positron emission tomography.
Farde L; Ehrin E; Eriksson L; Greitz T; Hall H; Hedström CG; Litton JE; Sedvall G
Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3863-7. PubMed ID: 3873656
[TBL] [Abstract][Full Text] [Related]
19. Raclopride, a new selective ligand for the dopamine-D2 receptors.
Hall H; Köhler C; Gawell L; Farde L; Sedvall G
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):559-68. PubMed ID: 2975809
[TBL] [Abstract][Full Text] [Related]
20. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
